Bisphosphonates therapy for osteoarthritis: a meta-analysis of randomized controlled trials

• Published in: SpringerPlus Vol. 5; no. 1; p. 1704
• Main Authors: Xing, R. L., Zhao, L. R., Wang, P. M.
• Format: Journal Article Book Review
• Language: English
• Published: Cham Springer International Publishing 03.10.2016; Springer Nature B.V
• Subjects: Humanities and Social Sciences; Medicine; multidisciplinary; Review; Science; Science (multidisciplinary); Bisphosphonates; Osteoarthritis; Meta-analysis
• ISSN: 2193-1801; 2193-1801
• DOI: 10.1186/s40064-016-3359-y

High-turnover type bone metabolism derangement has been considered to be one of the major causes of osteoarthritis (OA). Bisphosphonates can attach to hydroxyapatite binding sites on bony surfaces, particularly those which are undergoing active bone resorption. To evaluate the effectiveness of bisphosphonates in OA treatment, literature databases were searched from inception to February 28, 2016 for clinical studies of bisphosphonates for OA treatment. All randomized controlled trials in which bisphosphonates therapy was compared with a placebo or a conventional medication, were selected. 15/1145 studies were eligible for analysis, which included 3566 participants. Bisphosphonates therapy improved pain, stiffness and function significantly in OA assessed by the Western Ontario and McMaster Universities Arthritis Index scale (MD = 4.59; 95 % CI 2.83–6.34; P < 0.00001; MD = 1.43; 95 % CI 0.83–2.23; P = 0.0005; MD = 2.01; 95 % CI 1.27–2.75; P < 0.00001). Bisphosphonates also reduced osteophyte score significantly (MD = −0.51; 95 % CI −0.84 to −0.19; P = 0.002). However, no significant differences were found in subjective improvement, osteoarthritis progression, the number of required acetaminophen treatment or joint replacement. In conclusion, bisphosphonates therapy is effective in relieving pain,stiffness and accelerating functional recovery in OA. Limitations of the studies we analysed included the differences in duration of bisphosphonates use, the doses and types of bisphosphonates and the lack of long-term data on OA joint structure modification after bisphosphonates therapy. More targeted studies are required to evaluate on the effectiveness of bisphosphonates for OA treatment.